🧵 View Thread
🧵 Thread (5 tweets)

UltimApe@ultimape• over 3 years ago
Replying to @ultimape
The article is a description of an in progress study (at the time). My statement is there was no evidence yet. The study in question was literally the attempt to gather such evidence.They just flagged it because others sharing it are misrepresenting it. https://t.co/2TtqUPn2JS

UltimApe@ultimape• over 3 years ago
Replying to @ultimape
What does this mean?"Early treatment with molnupiravir reduced the risk of hospitalization or death in at-risk, unvaccinated adults with Covid-19. (Funded by Merck Sharp and Dohme; MOVe-OUT https://t.co/05F0BVdhhI number, NCT04575597. opens in new tab.)" https://t.co/4KzOuYggM8

UltimApe@ultimape• over 3 years ago
Replying to @ultimape
Do we have evidence of molnupiarvir yet?That does seem to be the phase three that was referenced here: https://t.co/wRsO2RVfhp